4949
Title:
4-Aza-17-gesubstitueerde-5alpha-androstaan-3-onen, de A- en D-homo- -analogen ervan, werkwijze voor de bereiding ervan en farmaceutische samenstellingen, die deze verbindingen bevatten.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
4949
WO Application Number:
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Expiry of maximum duration
Application number:
4949
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
EP4949;
Dates
Filing date:
12/04/1979
Grant date:
21/09/1983
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/10/1983
EP B1 Publication Date:
21/09/1983
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
01/11/1983
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/04/1999
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
12/04/1999
Applicant/holder
From:
12/04/1979
Name:
Merck & Co., Inc.
Address:
Rahway, New Jersey, United States of America (US)
Domicile Holder
Name:
Dr. R. Jorritsma c.s.
From:
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)